Concurrent chemoradiotherapy with or without low molecular weigth heparin (LWMH) in the treatment of locally avanced non-small cell lung cancer (NSCLC)

dc.contributor.authorIsikdogan, A.
dc.contributor.authorKaplan, M. A.
dc.contributor.authorZincircioglu, S. B.
dc.contributor.authorCit, M.
dc.contributor.authorCil, T.
dc.contributor.authorKaradayi, B.
dc.contributor.authorDirier, A.
dc.date.accessioned2024-04-24T17:14:57Z
dc.date.available2024-04-24T17:14:57Z
dc.date.issued2010
dc.departmentDicle Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1200/jco.2010.28.15_suppl.e17526
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue15en_US
dc.identifier.urihttps://doi.org/10.1200/jco.2010.28.15_suppl.e17526
dc.identifier.urihttps://hdl.handle.net/11468/18270
dc.identifier.volume28en_US
dc.identifier.wosWOS:000208852001339
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherAmer Soc Clinical Oncologyen_US
dc.relation.ispartofJournal of Clinical Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleConcurrent chemoradiotherapy with or without low molecular weigth heparin (LWMH) in the treatment of locally avanced non-small cell lung cancer (NSCLC)en_US
dc.titleConcurrent chemoradiotherapy with or without low molecular weigth heparin (LWMH) in the treatment of locally avanced non-small cell lung cancer (NSCLC)
dc.typeConference Objecten_US

Dosyalar